June 26, 2015
Note to readers:
The information provided below will likely generate more questions than I’m transparently able to answer at this time. Please know it is not my intention to deceive or manipulate, as that is inconsistent & contradictory to the goal of this site which is exposing the truth; and, I will provide more facts as I’m able-Thank you for your understanding-Melayna Lokosky
J&J Hit with New Multimillion-Dollar Fraud Suit
Acclarent, a startup acquired by Johnson & Johnson in 2010, knowingly marketed its Relieva Stratus MicroFlow spacer for an unproven drug delivery use, according to a former employee’s whistleblower complaint filed in Los Angeles Superior Court.
The new lawsuit, State of California exrel. Melayna Lokosky vs. Acclarent, Inc.;Ethicon, Inc.; and Johnson & Johnson, maintains that J&J, which acquiredAcclarent for $785 million in 2010, is culpable for millions of dollars in damages, as insurance companies were led to pay for Acclarent devices that were misbranded, medically unnecessary, and marketed to physicians for unproven off-label uses.
The rest of the story can be found on Qmed by Chris Newmarker & Brian Buntz
Information on the arrests & federals indictment of fomer Johnson & Johnson Ethicon Acclarent executives William (Bill) Facteau & Patrick (Pat) Fabian can be found here
The full complaint can be found here:
1871.7 Complaint (LASC — BC530372) (Filed Under Seal on 12-13-13)